Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

American Journal of Respiratory and Critical Care Medicine, 2022
Plasticity of Individual Lung Function States from Childhood to Adulthood

Wang G., Hallberg J., Faner R. et al.

Olink Target 96Respiratory DiseasesPatient StratificationPlasma

Antiviral Research, 2022
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier

Faist A., Schloer S., Mecate-Zambrano A. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Alzheimer's Research & Therapy, 2022
Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome

Dammer E., Ping L., Duong D. et al.

Olink Target 96NeurologyTechnical EvaluationPlasmaCSF

Scientific Reports, 2022
Plasma proteomic characterization of the development of acute kidney injury in early sepsis patients

Star B., Boahen C., van der Slikke E. et al.

Olink Target 96Infectious DiseasesNephrologyPathophysiologyPatient StratificationPlasma

Archives of Microbiology & Immunology, 2022
Circulating Cell-Free DNA and Systemic Inflammatory Response after Self-Expandable Metal Stent for Malignant Bowel Obstruction

Broholm M, Bojesen R, Gögenur M et al.

Olink Target 96OncologyPathophysiologyPlasma

Clinical Proteomics, 2022
Determination of temporal reproducibility and variability of cancer biomarkers in serum and EDTA plasma samples using a proximity extension assay

Christensen T., Maag E., Madsen K. et al.

Olink Target 96Technical StudiesTechnical EvaluationPlasmaSerum

Nature Aging, 2022
CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels

del Campo M., Peeters C., Johnson E. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationCSF

European Heart Journal Open, 2022
NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients

Rossignol P., Duarte K., Bresso E. et al.

Olink Target 96CVDNephrologyPathophysiologyPatient StratificationPlasma

Human Molecular Genetics, 2022
Identifying causal serum protein–cardiometabolic trait relationships using whole genome sequencing

Png G., Gerlini R., Hatzikotoulas K. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologySerum

BMJ Open Diabetes Research & Care, 2022
Pregnancy induces pancreatic insulin secretion in women with long-standing type 1 diabetes

Espes D., Magnusson L., Caballero-Corbalan J. et al.

Olink Target 96Metabolic DiseasesObstetricsPathophysiologyPlasma

PLOS ONE, 2022
Protein biomarker profiles in serum and CSF in 158 patients with PTLDS or persistent symptoms after presumed tick-bite exposure compared to those in patients with confirmed acute neuroborreliosis

Nilsson K., Skoog E., Edvinsson M. et al.

Olink Target 96Infectious DiseasesPatient StratificationSerumCSF

Obesity, 2022
Proteomics, dietary intake, and changes in cardiometabolic health within a behavioral weight‐loss intervention: A pilot study

Hill E., Siebert J., Yazza D. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma

Journal for ImmunoTherapy of Cancer, 2022
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors

Natoli M., Hatje K., Gulati P. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyCell Lysate

Scientific Reports, 2022
Discovery of four plasmatic biomarkers potentially predicting cardiovascular outcome in peripheral artery disease

Kremers B., Posma J., Heitmeier S. et al.

Olink Target 96CVDPatient StratificationPlasma

Journal for ImmunoTherapy of Cancer, 2022
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors

Davis E., Martin-Liberal J., Kristeleit R. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Biomedicines, 2022
Quantitative Proteomics Indicate Radical Removal of Non-Small Cell Lung Cancer and Predict Outcome

Bodén E., Andreasson J., Hirdman G. et al.

Olink Target 96OncologyPatient StratificationPlasma

Journal of Proteome Research, 2022
Plasma Olink Proteomics Identifies CCL20 as a Novel Predictive and Diagnostic Inflammatory Marker for Preeclampsia

Wang X., Yip K., He A. et al.

Olink Target 96ObstetricsPatient StratificationPlasma

Mucosal Immunology, 2022
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity and inflammation due to dysregulated immunometabolism

Cavounidis A., Pandey S., Capitani M. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma

The Journal of Clinical Endocrinology & Metabolism, 2022
The Acute Cytokine Response to 30-Minute Exercise Bouts Before and After 8-Week Endurance Training in Individuals With Obesity

Goj T., Hoene M., Fritsche L. et al.

Olink Target 96Metabolic DiseasesPathophysiologySerum

Nature Genetics, 2022
Multiomics study of nonalcoholic fatty liver disease

Sveinbjornsson G., Ulfarsson M., Thorolfsdottir R. et al.

Olink Explore 3072/384HepatologyPathophysiologyPatient StratificationPlasma

3478 publications